Iridex Corporation is a global leader in providing innovative laser-based medical systems and devices for treating glaucoma and retinal diseases. The company operates primarily in the ...

MOUNTAIN VIEW, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...

The revised LCD reimbursement change for glaucoma is expected to encourage more procedures using IRIDEX Corp (NASDAQ:IRIX)'s laser consoles and probes, potentially increasing adoption. Revenue for ...

Iridex Corp. (IRIX) on Tuesday reported a loss of $1.9 million in its third quarter. The Mountain View, California-based company said it had ...

Sold 13,600 Cyclo G6 probes, compared to 13,200 in the prior year period Sold 26 Cyclo G6 Glaucoma Laser Systems, compared to 27 in the prior year period The future potential for Iridex’s ...

Among other things, the changing reimbursement landscape for glaucoma treatments is bringing favorable attention to Iridex and the value of our efficient and efficacious laser procedures.” "Last year, ...

Among other things, the changing reimbursement landscape for glaucoma treatments is bringing favorable attention to Iridex and the value of our efficient and efficacious laser ...